why choose us

First received: June 25, 2025

Clinical Trial: A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hepatic Insufficiency

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Single-Dose Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of MK-3543

Brief Summary: The purpose of this study is to learn what happens to bomedemstat (MK-3543) in a person's body over time.Researchers will compare what happens to bomedemstat in the body when it is given to participants with mild or moderate hepatic (liver) impairment and healthy participants.Participants will be allocated to one of three groups: mild hepatic impairment (HI), moderate HI, or healthy matched control.All participants will receive a single oral dose of bomedemstat on Day 1.Healthy control participants will be…

Read more